27 institutions looking for ways to boost immune system to fight cancer
The University of California, San Diego School of Medicine is among 27 research institutions selected across North America to be a part of the Cancer Immunotherapy Trials Network (CITN), funded by the National Cancer Institute (NCI). The CITN will establish a network of top academic immunologists to conduct multicenter research on agents that boost patients’ own immune systems to fight their cancer. … Read the full story from the UCSD Newsroom
Dr. Thomas Kipps, pictured above, is principal investigator of the UC San Diego CITN study site. Thomas J. Kipps, MD, PhD, is Professor of Medicine in the Division of Hematology-Oncology and deputy director of the UC San Diego Moores Cancer Center. He holds the Evelyn and Edwin Tasch Chair in Cancer Research. Read more about the Cancer Immunotherapy Trials Network.